Get it on Google Play

EU panel backs Enhertu for early HER2-positive breast cancer

September 18, 2026 8:00 AM EDT Send to a Friend
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login